Clinical Trials on Empaglifozin

Total 8 results

Aristotle University Of Thessaloniki

Recruiting

Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Cardiovascular Prevention | Tissue Oxygenation | Empagliflozin | SGLT2-Inhibitors | Hematocrit Change

Greece
West China Hospital

Not yet recruiting

Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

Kidney Transplantation | Metabolic Disorder | Metformin | Empagliflozin
National Institute on Aging (NIA)

Completed

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Physiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 Inhibitors

United States
SINA Health Education and Welfare Trust
Horizon Pharmaceutical Pvt Ltd

Completed

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | Empagliflozin

Pakistan
Chulalongkorn University

Recruiting

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

Empagliflozin in Post AKI Stage 2-3

Thailand
Chulalongkorn University

Not yet recruiting

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 (TREAT-CRS)

Empagliflozin in Cardiorenal Syndrome Type 1

Thailand
The University of Hong Kong
Research Grant Council

Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

Cirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 Inhibitors

Hong Kong
Yonsei University

Completed

Antidiabetic Drugs for Steatotic Liver Disease

Liver Diseases | Fatty Liver | Type 2 Diabetes | Molecular Mechanisms of Pharmacological Action | Digestive System Disease | Non-Alcoholic Fatty Liver Disease | Physiological Effects of Drugs | Hypoglycemic Agents | Empagliflozin | Pioglitazone | Metabolic Dysfunction-Associated Steatotic Liver Disease | MASLD... and other conditions

Korea, Republic of

Clinical Trials on Empaglifozin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations